awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38542092-2CF015A1-CC25-46CE-9EA0-13E7BC5AE32A
Q38542092-2CF015A1-CC25-46CE-9EA0-13E7BC5AE32A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38542092-2CF015A1-CC25-46CE-9EA0-13E7BC5AE32A
Inhibition of bromodomain and extra-terminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence.
P2860
Q38542092-2CF015A1-CC25-46CE-9EA0-13E7BC5AE32A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38542092-2CF015A1-CC25-46CE-9EA0-13E7BC5AE32A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3a2d4efb2a2ed8793d1f42ab72409eaa1f804607
P2860
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.